drugset / Trial / NCT02586285

Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma

NCT02586285

Phase 1 Unknown 300 enrolled Eastern Hepatobiliary Surgery Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to explore the effect of S-Adenosyl Methionine on recurrence after curative resection of Hepatocellular Carcinoma.

Timeline

Start
2015-06
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator S-adenosylmethionine Other / unclassified 500 mg Intravenous
Comparator S-adenosylmethionine Other / unclassified 1000 mg Intravenous